MARTIN JOHN C 4
4 · Sarepta Therapeutics, Inc. · Filed Feb 28, 2020
Insider Transaction Report
Form 4
MARTIN JOHN C
Director
Transactions
- Award
Common Stock
2020-02-28+3,112→ 3,112 total - Award
Common Stock
2020-02-28+2,075→ 5,187 total - Award
Stock option (right to buy)
2020-02-28+5,528→ 5,528 totalExercise: $114.47Exp: 2020-02-28→ Common Stock (5,528 underlying) - Award
Stock option (right to buy)
2020-02-28+3,685→ 3,685 totalExercise: $114.47From: 2021-02-28Exp: 2020-02-28→ Common Stock (3,685 underlying)
Footnotes (3)
- [F1]The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs vest in three equal annual installments beginning February 28, 2021.
- [F2]The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on February 28, 2021.
- [F3]The option vests in three equal annual installments beginning February 28, 2021.